The future of genetic engineering. In it we cover de-extinction, growing the Woolly Mammoth, human longevity, AI-led drug discovery, and the future of biotech.

Ben Lamm is CEO of Colossal Biosciences, a Texas based biotech company on a mission to safeguard our worlds biodiversity and re-wild our planet. As part of that they are endeavoring to bring back extinct species such as the Woolly Mammoth, the Dodo, and the Tasmanian Tiger by as as early as 2028. Colossal has raised $225M to date and is a truly revolutionary organization pushing the frontier of genetic engineering with some of the leading minds in the field. The innovations developed from their research has impacts beyond animal conservation and advances our ability to fight diseases, uncover new drugs, protect our climate, reproduce successfully, and extend human lifespan. Ben comes from a software background and successfully built and sold three companies prior to Colossal. He brings to the world of science the energy and unique thinking of a software entrepreneur at a time when AI and computational biology is really propelling the field in leaps and bounds. Ben is prolific in the world of scientific innovation, sitting on the board of the Planetary Society, The Explorers Club, as well as owning the award winning science publication Nautilus.

Subscribe for the latest episodes. Email me on danieldarling@focal.vc

The future of genetic engineering. In it we cover de-extinction, growing the Woolly Mammoth, human longevity, AI-led drug discovery, and the future of biotech.
Ben Lamm is CEO of Colossal Biosciences, a Texas based biotech company on a mission to safeguard our worlds biodiversity and re-wild our planet. As part of that they are endeavoring to bring back extinct species such as the Woolly Mammoth, the Dodo, and the Tasmanian Tiger by as as early as 2028. Colossal has raised $225M to date and is a truly revolutionary organization pushing the frontier of genetic engineering with some of the leading minds in the field. The innovations developed from their research has impacts beyond animal conservation and advances our ability to fight diseases, uncover new drugs, protect our climate, reproduce successfully, and extend human lifespan. Ben comes from a software background and successfully built and sold three companies prior to Colossal. He brings to the world of science the energy and unique thinking of a software entrepreneur at a time when AI and computational biology is really propelling the field in leaps and bounds. Ben is prolific in the world of scientific innovation, sitting on the board of the Planetary Society, The Explorers Club, as well as owning the award winning science publication Nautilus.
Subscribe for the latest episodes. Email me on <a href="mailto:danieldarling@focal.vc">danieldarling@focal.vc</a>

Fast forward 5 years to view the future of an industry through the eyes of its most innovative entrepreneurs and CEOs.

Learn what key industries could look like in 5 years.

Witness the evolution through the eyes of leading CEOs.

Discover who gets disrupted and who wins big.

Hear of mind blowing technology set to reinvent all the rules.

Reshape your mental model to thrive in the change ahead.

Delivered as short (~30 mins), insight-packed discussions, that will spark imagination and leave listeners with a preview of what lies ahead.

Fast forward 5 years to view the future of an industry through the eyes of its most innovative entrepreneurs and CEOs.
Learn what key industries could look like in 5 years.
Witness the evolution through the eyes of leading CEOs.
Discover who gets disrupted and who wins big.
Hear of mind blowing technology set to reinvent all the rules.
Reshape your mental model to thrive in the change ahead.
Delivered as short (~30 mins), insight-packed discussions, that will spark imagination and leave listeners with a preview of what lies ahead.

5 Year Frontier

#17: Defeating death, programming life, resurrecting the Woolly Mammoth, AI’s blueprint for biotech, and the future of genetic engineering w/ Colossal Biosciences CEO Ben Lamm

Advertisement